BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 22926301)

  • 1. Associations of circulating retinol, vitamin E, and 1,25-dihydroxyvitamin D with prostate cancer diagnosis, stage, and grade.
    Gilbert R; Metcalfe C; Fraser WD; Donovan J; Hamdy F; Neal DE; Lane JA; Martin RM
    Cancer Causes Control; 2012 Nov; 23(11):1865-73. PubMed ID: 22926301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade.
    Gilbert R; Metcalfe C; Fraser WD; Donovan J; Hamdy F; Neal DE; Lane JA; Martin RM
    Int J Cancer; 2012 Sep; 131(5):1187-96. PubMed ID: 22033893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case-control study.
    Gilbert R; Bonilla C; Metcalfe C; Lewis S; Evans DM; Fraser WD; Kemp JP; Donovan JL; Hamdy FC; Neal DE; Lane JA; Smith GD; Lathrop M; Martin RM
    Cancer Causes Control; 2015 Feb; 26(2):205-218. PubMed ID: 25488826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies.
    Key TJ; Appleby PN; Travis RC; Albanes D; Alberg AJ; Barricarte A; Black A; Boeing H; Bueno-de-Mesquita HB; Chan JM; Chen C; Cook MB; Donovan JL; Galan P; Gilbert R; Giles GG; Giovannucci E; Goodman GE; Goodman PJ; Gunter MJ; Hamdy FC; Heliövaara M; Helzlsouer KJ; Henderson BE; Hercberg S; Hoffman-Bolton J; Hoover RN; Johansson M; Khaw KT; King IB; Knekt P; Kolonel LN; Le Marchand L; Männistö S; Martin RM; Meyer HE; Mondul AM; Moy KA; Neal DE; Neuhouser ML; Palli D; Platz EA; Pouchieu C; Rissanen H; Schenk JM; Severi G; Stampfer MJ; Tjønneland A; Touvier M; Trichopoulou A; Weinstein SJ; Ziegler RG; Zhou CK; Allen NE;
    Am J Clin Nutr; 2015 Nov; 102(5):1142-57. PubMed ID: 26447150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of circulating 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and vitamin D pathway genes with prostate-specific antigen progression in men with localized prostate cancer undergoing active monitoring.
    Gilbert R; Metcalfe C; Fraser WD; Lewis S; Donovan J; Hamdy F; Neal DE; Lane JA; Martin RM; Tilling K
    Eur J Cancer Prev; 2013 Mar; 22(2):121-5. PubMed ID: 22955340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
    Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
    J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D, season, and risk of prostate cancer: a nested case-control study within Norwegian health studies.
    Meyer HE; Robsahm TE; Bjørge T; Brustad M; Blomhoff R
    Am J Clin Nutr; 2013 Jan; 97(1):147-54. PubMed ID: 23193007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
    Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
    PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association among plasma 1,25(OH)
    Ramakrishnan S; Steck SE; Arab L; Zhang H; Bensen JT; Fontham ETH; Johnson CS; Mohler JL; Smith GJ; Su LJ; Woloszynska A
    Prostate; 2019 Jul; 79(10):1117-1124. PubMed ID: 31077420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Schenk JM; Riboli E; Chatterjee N; Leitzmann MF; Ahn J; Albanes D; Reding DJ; Wang Y; Friesen MD; Hayes RB; Peters U
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1227-31. PubMed ID: 19336558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk.
    Travis RC; Perez-Cornago A; Appleby PN; Albanes D; Joshu CE; Lutsey PL; Mondul AM; Platz EA; Weinstein SJ; Layne TM; Helzlsouer KJ; Visvanathan K; Palli D; Peeters PH; Bueno-de-Mesquita B; Trichopoulou A; Gunter MJ; Tsilidis KK; Sánchez MJ; Olsen A; Brenner H; Schöttker B; Perna L; Holleczek B; Knekt P; Rissanen H; Yeap BB; Flicker L; Almeida OP; Wong YYE; Chan JM; Giovannucci EL; Stampfer MJ; Ursin G; Gislefoss RE; Bjørge T; Meyer HE; Blomhoff R; Tsugane S; Sawada N; English DR; Eyles DW; Heath AK; Williamson EJ; Manjer J; Malm J; Almquist M; Marchand LL; Haiman CA; Wilkens LR; Schenk JM; Tangen CM; Black A; Cook MB; Huang WY; Ziegler RG; Martin RM; Hamdy FC; Donovan JL; Neal DE; Touvier M; Hercberg S; Galan P; Deschasaux M; Key TJ; Allen NE
    Cancer Res; 2019 Jan; 79(1):274-285. PubMed ID: 30425058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    Shui IM; Mondul AM; Lindström S; Tsilidis KK; Travis RC; Gerke T; Albanes D; Mucci LA; Giovannucci E; Kraft P;
    Cancer; 2015 Jun; 121(12):1949-56. PubMed ID: 25731953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D deficiency predicts prostate biopsy outcomes.
    Murphy AB; Nyame Y; Martin IK; Catalona WJ; Hollowell CM; Nadler RB; Kozlowski JM; Perry KT; Kajdacsy-Balla A; Kittles R
    Clin Cancer Res; 2014 May; 20(9):2289-99. PubMed ID: 24789033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using genetic proxies for lifecourse sun exposure to assess the causal relationship of sun exposure with circulating vitamin d and prostate cancer risk.
    Bonilla C; Gilbert R; Kemp JP; Timpson NJ; Evans DM; Donovan JL; Hamdy FC; Neal DE; Fraser WD; Davey SG; Lewis SJ; Lathrop M; Martin RM
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):597-606. PubMed ID: 23441100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of folate, lycopene, β-carotene, retinol and vitamin E and prostate cancer risk.
    Beilby J; Ambrosini GL; Rossi E; de Klerk NH; Musk AW
    Eur J Clin Nutr; 2010 Oct; 64(10):1235-8. PubMed ID: 20683458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum 25-hydroxyvitamin D, vitamin D binding protein, and prostate cancer risk in black men.
    Layne TM; Weinstein SJ; Graubard BI; Ma X; Mayne ST; Albanes D
    Cancer; 2017 Jul; 123(14):2698-2704. PubMed ID: 28369777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Travis RC; Crowe FL; Allen NE; Appleby PN; Roddam AW; Tjønneland A; Olsen A; Linseisen J; Kaaks R; Boeing H; Kröger J; Trichopoulou A; Dilis V; Trichopoulos D; Vineis P; Palli D; Tumino R; Sieri S; Bueno-de-Mesquita HB; van Duijnhoven FJ; Chirlaque MD; Barricarte A; Larrañaga N; González CA; Argüelles MV; Sánchez MJ; Stattin P; Hallmans G; Khaw KT; Bingham S; Rinaldi S; Slimani N; Jenab M; Riboli E; Key TJ
    Am J Epidemiol; 2009 May; 169(10):1223-32. PubMed ID: 19359375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial.
    Schenk JM; Till CA; Tangen CM; Goodman PJ; Song X; Torkko KC; Kristal AR; Peters U; Neuhouser ML
    Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1484-93. PubMed ID: 25085836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
    Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions Between Genome-Wide Significant Genetic Variants and Circulating Concentrations of 25-Hydroxyvitamin D in Relation to Prostate Cancer Risk in the National Cancer Institute BPC3.
    Dimitrakopoulou VI; Travis RC; Shui IM; Mondul A; Albanes D; Virtamo J; Agudo A; Boeing H; Bueno-de-Mesquita HB; Gunter MJ; Johansson M; Khaw KT; Overvad K; Palli D; Trichopoulou A; Giovannucci E; Hunter DJ; Lindström S; Willett W; Gaziano JM; Stampfer M; Berg C; Berndt SI; Black A; Hoover RN; Kraft P; Key TJ; Tsilidis KK
    Am J Epidemiol; 2017 Mar; 185(6):452-464. PubMed ID: 28399564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.